|
Video: What is a Stock Split?
|
|
Vyant Bio is a biotechnology company reinventing drug discovery for neurodevelopmental and neurodegenerative disorders. Co.'s central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. Co.'s platform is designed to: elucidate disease pathophysiology; formulate therapeutic hypotheses; identify and validate drug targets, cellular assays, and biomarkers; and guide clinical trial patient selection and trial design. Co.'s programs are focused on identifying small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome, CDKL5 Deficiency Disorders and Parkinson's Disease. According to our VYNT split history records, Vyant Bio has had 1 split. | |
|
Vyant Bio (VYNT) has 1 split in our VYNT split history database. The split for VYNT took place on November 02, 2022. This was a 1 for 5 reverse split, meaning for each 5 shares of VYNT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split.
When a company such as Vyant Bio conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the VYNT split history from start to finish, an original position size of 1000 shares would have turned into 200 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Vyant Bio shares, starting with a $10,000 purchase of VYNT, presented on a split-history-adjusted basis factoring in the complete VYNT split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/30/2014 |
|
End date: |
05/24/2023 |
|
Start price/share: |
$73.50 |
|
End price/share: |
$0.24 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.67% |
|
Average Annual Total Return: |
-46.80% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$32.63 |
|
Years: |
9.07 |
|
|
|
Date |
Ratio |
11/02/2022 | 1 for 5 |
|
|